This website cannot be viewed properly using Internet Explorer.

Viewing the site in Internet Explorer will cause functionality and security issues across the site. To avoid this, please use a modern browser such as Chrome, Firefox, Safari or update Internet Explorer to Microsoft Edge.

Improving Healthcare
for Women

TRUE + Visana: Partnering for Women’s Health

True Health New Mexico has partnered with Visana Health, a digital platform for chronic gynecological conditions, to provide enhanced support for our members who have endometriosis, chronic pelvic pain, heavy menstrual bleeding, and uterine fibroids. These conditions affect 20 to 40% of reproductive-aged women and cost the healthcare system billions of dollars every year. [1-5]

Due to a lack of access to healthcare professionals specializing in women’s health (dietitians, clinical psychologists, pelvic floor physical therapists), a difficult diagnostic pathway, and a lack of patient awareness due to the stigmatized nature of gynecological conditions, women often: [6-10]

  • Experience a long diagnostic delay,
  • Do not receive multidisciplinary care including nutrition, pelvic floor physical therapy, and/or cognitive behavioral therapy, and
  • Suffer from untreated mental health complications including depression and anxiety.

Visana Health provides True Health New Mexico members with gynecological conditions with personalized, evidence-based digital programs that include diet and nutrition information, disease and treatment education, cognitive behavioral strategies, and pelvic floor relaxation exercises.

Visana also pairs members with a health coach who ensure women develop healthy habits. Ultimately, Visana’s goal is to create behavior changes that are clinically proven to improve outcomes and increase patient awareness of gynecological diseases and associated treatments. [11]

Visana does not provide medical care and is designed to enhance the patient-provider experience. Their goal is to raise True Health New Mexico member awareness of gynecological conditions and treatment options, so members come to gynecologists better educated about their options. Additionally, Visana’s content is created by dietitians, pelvic floor physical therapists, and clinical psychologists – resources that can be difficult to make readily available to your patients.

Visana will complement your current clinical services and create more productive and efficient office visits. 

For information about the program, eligibility, and more, please visit our Women’s Health and Wellness page.

Sources
  1. Cardozo, Eden R et al. “The estimated annual cost of uterine leiomyomata in the United States.” American Journal of Obstetrics and Gynecology, Vol. 206, Issue 3, 2012: 211.e1-9. doi:10.1016/j.ajog. 2011.12.002
  2. Ahmed M. Soliman, Hongbo Yang, Ella Xiaoyan Du, Caroline Kelley, Craig Winkel, “The direct and indirect costs associated with endometriosis: a systematic literature review.” Human Reproduction, Vol. 31, Issue 4, April 2016, pp. 712–722, https://doi.org/10.1093/humrep/dev335.
  3. Fraser et al. “Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey.” International Journal of Gynecology & Obstetrics. March 2015. 128(3):1206-200.
  4. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. “Epidemiology of uterine fibroids: a systematic review.” BJOG 2017; 124:1501–1512.
  5. Latthe, P., Latthe, M., Say, L., Gulmezoglu, M., Khan, K. S. “WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity.” BMC Public Health. 2006;6(177), https://doi.org/10.1186/1471-2458-6-177.
  6. Ballard, K., Lowton, K., Wright, J. “What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis.” Fertility and Sterility. 2006;86(5):1296-1301, https://pubmed.ncbi.nlm.nih.gov/17070183/.
  7. Seear, K. “The etiquette of endometriosis: Stigmatisation, menstrual concealment and the diagnostic delay.” Social Science & Medicine. 2009;69(8):1220-1227, https://pubmed.ncbi.nlm.nih.gov/19699572/.
  8. Hudelist, G., Fritzer, N., Thomas, A., Niehues, C., Oppelt, P., Haas, D., Tammaa, A., Salzer, H. “Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences.” Human Reproduction. 2012;27(12):3412-3416, https://pubmed.ncbi.nlm.nih.gov/22990516/.
  9. Sepulcri, R., do Amaral, V.F. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2009;142(1):53–56, https://pubmed.ncbi.nlm.nih.gov/19010584/.
  10. Ghant MS, Sengoba KS, Recht H, Cameron KA, Lawson AK, Marsh EE. “Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women’s emotional and psychosocial health.” Journal of Psychosomatic Research. 2015;78(5):499-503. doi:10.1016/j.jpsychores.2014.12.016
  11. Peters, A., van Dorst, E., Jellis, B., van Zuuren, J., Hermans, J., Trimbos, J.B. “A randomized clinical trial to compare two different approaches in women with chronic pelvic pain.” Obstetrics & Gynecology. 1991;77(5):740–744, https://pubmed.ncbi.nlm.nih.gov/1826544/.